NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020)
NovaBridge Biosciences (NBP) reported Long-Term Debt Repayments of $15.1 million for Q4 2020, down 33.53% year-over-year from $22.7 million in Q1 2020, and down 33.53% quarter-over-quarter from $22.7 million in Q4 2019.
NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has 2 years of Long-Term Debt Repayments data on file, last reported at $15.1 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | - |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | NovaBridge Biosciences | 331.49 Mn | 120.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2019 | 22.70 Mn |
| Dec 31, 2019 | 22.70 Mn |